Holen Sie sich die Stockscreener-App
270.53
0.96%
2.57
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CI?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$267.96
Offen:
$270.03
24-Stunden-Volumen:
1.91M
Relative Volume:
1.16
Marktkapitalisierung:
$71.48B
Einnahmen:
$278.13B
Nettoeinkommen (Verlust:
$6.74B
KGV:
11.46
EPS:
23.6047
Netto-Cashflow:
$7.66B
1W Leistung:
-0.54%
1M Leistung:
-4.35%
6M Leistung:
+0.19%
1J Leistung:
-8.91%
1-Tages-Spanne:
$266.00
$271.40
1-Wochen-Bereich:
$262.85
$278.88
52-Wochen-Spanne:
$239.51
$315.47
Cigna Group Stock (CI) Company Profile
Firmenname
Cigna Group
Sektor
Branche
Telefon
(860) 226-6000
Adresse
900 COTTAGE GROVE ROAD, BLOOMFIELD, CT
Compare CI vs UNH, CVS, ELV, HUM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CI
Cigna Group
|
270.53 | 71.88B | 278.13B | 6.74B | 7.66B | 23.60 |
UNH
Unitedhealth Group Inc
|
371.90 | 327.80B | 450.13B | 14.91B | 23.62B | 15.55 |
CVS
Cvs Health Corp
|
86.46 | 113.99B | 407.94B | 2.90B | 7.39B | 2.2771 |
ELV
Elevance Health Inc
|
386.43 | 85.90B | 201.11B | 4.95B | 6.29B | 22.50 |
HUM
Humana Inc
|
388.36 | 47.78B | 137.20B | 1.15B | 1.27B | 9.3439 |
Cigna Group Stock (CI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-12 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2025-10-14 | Eingeleitet | Goldman | Buy |
| 2025-02-06 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2024-06-26 | Eingeleitet | Piper Sandler | Overweight |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-03-06 | Eingeleitet | Barclays | Overweight |
| 2024-02-05 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2024-02-05 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-02-01 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-01-04 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2023-12-11 | Hochstufung | Jefferies | Hold → Buy |
| 2023-08-18 | Herabstufung | Edward Jones | Buy → Hold |
| 2023-06-06 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2023-04-05 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-01-03 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-11-23 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-11-21 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2022-07-14 | Herabstufung | Jefferies | Buy → Hold |
| 2022-06-22 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-06-17 | Eingeleitet | Loop Capital | Hold |
| 2022-05-27 | Fortgesetzt | Bernstein | Mkt Perform |
| 2022-05-26 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-05-16 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2022-05-09 | Hochstufung | Cowen | Market Perform → Outperform |
| 2022-02-07 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-02-04 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-01-06 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2021-12-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-12-16 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-12-14 | Eingeleitet | Goldman | Neutral |
| 2021-11-17 | Eingeleitet | Seaport Research Partners | Buy |
| 2021-09-27 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2021-09-10 | Herabstufung | BofA Securities | Buy → Underperform |
| 2021-09-10 | Eingeleitet | Cowen | Market Perform |
| 2021-08-06 | Bestätigt | BofA Securities | Buy |
| 2021-08-06 | Bestätigt | Citigroup | Buy |
| 2021-08-06 | Bestätigt | Deutsche Bank | Buy |
| 2021-08-06 | Bestätigt | Jefferies | Buy |
| 2021-08-06 | Bestätigt | Mizuho | Buy |
| 2021-08-06 | Bestätigt | Oppenheimer | Outperform |
| 2021-08-06 | Bestätigt | Truist | Buy |
| 2021-05-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-07-01 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2020-05-04 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2020-03-24 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2019-12-11 | Herabstufung | Wells Fargo | Market Perform → Underperform |
| 2019-10-18 | Eingeleitet | Mizuho | Buy |
| 2019-09-30 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Buy |
| 2019-08-06 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2019-04-23 | Eingeleitet | UBS | Buy |
| 2019-01-14 | Eingeleitet | Stephens | Overweight |
| 2018-12-24 | Eingeleitet | Edward Jones | Buy |
| 2018-03-13 | Eingeleitet | Bernstein | Mkt Perform |
| 2018-03-08 | Eingeleitet | Barclays | Overweight |
| 2018-01-03 | Eingeleitet | Goldman | Neutral |
| 2017-11-03 | Bestätigt | RBC Capital Mkts | Outperform |
| 2017-06-22 | Bestätigt | RBC Capital Mkts | Outperform |
| 2017-06-12 | Eingeleitet | Credit Suisse | Outperform |
| 2017-06-07 | Eingeleitet | Morgan Stanley | Overweight |
| 2017-05-08 | Bestätigt | RBC Capital Mkts | Outperform |
| 2017-04-05 | Eingeleitet | Deutsche Bank | Buy |
Alle ansehen
Cigna Group Aktie (CI) Neueste Nachrichten
FBT Gibbons Beats DQ Bid In Suit Over Cigna Payments - Law360
Cigna Better Positioned to Meet Long-Term EPS Growth Targets, RBC Says - marketscreener.com
UBS reiterates Cigna stock buy rating on 2026-2030 outlook By Investing.com - Investing.com Canada
Cigna rated 'Strong Buy' with strong Q2 results and 10-14% EPS growth target through 2030. - Pluang
Cigna: Deeply Undervalued With Expected Double-Digit EPS Growth Ahead - Seeking Alpha
Jefferies Adjusts Price Target on Cigna Group to $288 From $307, Keeps Hold Rating - marketscreener.com
The Cigna Group (CI) Stock Forecasts - Yahoo Finance
The Cigna Group Unveils Lead to One and $3 Billion Plan at Investor Day - Grit Daily News
Cigna Group (CI), What Is Behind The Fresh Attention? - Yahoo Finance
After Investment Year in 2026, Cigna Aims to Reaccelerate Profit Growth - Morningstar
HCA Houston and Cigna locked in new contract dispute with deal set to expire - The Business Journals
Cigna Sets Long-Term Goals, Unveils 2030 Modernization Strategy - Benzinga
Cigna options flow turns bullish even as technicals signal sell - Investing.com
Cigna, Fla. Atty Resolve $21M Claim In Ch. 7 Case - Law360
What Cigna Group (CI)'s $3 Billion Modernization Plan Means For Shareholders - Simply Wall Street
Cigna Reaffirms 2026 Outlook, Targets Complex Care and AI-Driven Growth - Yahoo Finance
The Cigna Group (CI) Analyst/Investor DaySlideshow (NYSE:CI) 2026-09-30 - Seeking Alpha
Cigna Group expects $3B in savings driven by AI, automation - Modern Healthcare
Cigna Outlines $3 Billion Modernization, Productivity Initiative - 富途牛牛
The Cigna Group (CI) Reaffirms 2026 Outlook and Sets 10-14% Long-Term Adjusted EPS Growth Target at Investor Day - GuruFocus
Cigna launches $3B cost-savings initiative focused on AI, automation - Hartford Business Journal
Cigna Stock: Specialty Drug Growth Takes Focus at Investor Day - Barron's
Cigna Group (CI) Reaffirms FY26 Guidance Amid Investor Day Insig - GuruFocus
Cigna (CI) Unveils $3 Billion AI Initiative, Reaffirms 2026 Guid - GuruFocus
Cigna expects $3 billion in cost savings by 2030 - reuters.com
Cigna sets aside $3B to boost performance (CI:NYSE) - Seeking Alpha
Will New CEO’s Specialty Pharmacy Focus Reshape Cigna Group’s (CI) Evernorth and Signature Narrative? - Yahoo Finance
Cigna Group stock tracks new 2030 earnings targets - AD HOC NEWS
Cigna Group reaffirms 2026 outlook at investor day - StreetInsider
Cigna unveils $3B modernization plan and targets 10-14% EPS growth through 2030 with new personalization strategy - Pluang
The Cigna Group reaffirms 2026 guidance, unveils "Lead to One" and $3B modernization plan - TradingView
The Cigna Group Hosts 2026 Investor Day Introduces "Lead To One" To Drive Durable Growth Through Complex Care Leadership And Differentiated Capabilities - TradingView
Cigna To Ramp Up Investments In Specialty Pharmacy And Complex Care - currently.att.yahoo.com
Cigna unveils $3B productivity initiative, including use of AI - Healthcare Dive
Have Cigna insurance? Your St. David’s care could cost more starting Thursday - Austin American-Statesman
Cigna, OpenAI partner on AI-driven personalized cancer care - TechTarget
Cigna Group stock trades flat as Investor Day nears - AD HOC NEWS
Cigna Group stock outperforms competitors on strong trading day - MarketWatch
Cigna and OpenAI collaborate on complex condition support - Healthcare Finance News
Cigna Group and OpenAI Partner to Support Patients With Complex Conditions - Digital Health News
The Cigna Group stock falls 1.03 percent after Q2 beat - AD HOC NEWS
Cigna Group (CI) Looks 58% Undervalued, Is The Recent Pullback A Buying Opportunity? - simplywall.st
Cigna Group stock slips 4.3 percent ahead of the open - AD HOC NEWS
Cigna Group, OpenAI team up to support patients with complex conditions - Fierce Healthcare
Cigna Group stock underperforms Thursday when compared to competitors - MarketWatch
UHC, Cigna and Centene Sign On to New National Shared Credentialing Program - MedCity News
Cigna Group, OpenAI partner to expand complex condition care - Modern Healthcare
The Cigna Group (CI) Stock Price, News, Quote & History - Yahoo! Finance Canada
Cigna Group stock slips 0.32 percent ahead of the open - AD HOC NEWS
Cigna Group stock underperforms Wednesday when compared to competitors - MarketWatch
Cigna allegedly ran the clock on a teen's mental health claims - insurancebusinessmag.com
Finanzdaten der Cigna Group-Aktie (CI)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):